Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma.
This study implied that E2F3/6/7 are potential targets of precision therapy for patients with LC and that E2F1/2/4/5/8 are new biomarkers for the prognosis of LC.
PMID: 29754146 [PubMed - as supplied by publisher]
Source: Aging - Category: Biomedical Science Authors: Sun CC, Zhou Q, Hu W, Li SJ, Zhang F, Chen ZL, Li G, Bi ZY, Bi YY, Gong FY, Bo T, Yuan ZP, Hu WD, Zhan BT, Zhang Q, Tang QZ, Li DJ Tags: Aging (Albany NY) Source Type: research
More News: Adenocarcinoma | Biomedical Science | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Genetics | Lung Cancer | Squamous Cell Carcinoma | Study